Difference between revisions of "Invasive breast cancer"

Jump to navigation Jump to search
m
Line 114: Line 114:
| Familial breast and ovarian cancer<ref name=omim113705>{{OMIM|113705}}</ref>
| Familial breast and ovarian cancer<ref name=omim113705>{{OMIM|113705}}</ref>
| male breast, ovarian, prostate, pancreas, fallopian tube
| male breast, ovarian, prostate, pancreas, fallopian tube
| younger individual vis-à-vis BRCA2
| younger individuals vis-à-vis BRCA2
|-
|-
| BRCA2
| BRCA2
| Familial breast and ovarian cancer 2<ref name=omim600185>{{OMIM|600185}}</ref>
| Familial breast and ovarian cancer 2<ref name=omim600185>{{OMIM|600185}}</ref>
| male breast, ovarian, prostate, pancreas, stomach, melanoma, gallbladder, bile duct, pharynx
| male breast, ovarian, prostate, pancreas, stomach, melanoma, gallbladder, bile duct, pharynx
| older individual vis-à-vis BRCA1
| older individuals vis-à-vis BRCA1
|-  
|-  
| TP53 (p53)
| TP53 (p53)
Line 134: Line 134:
| [[Peutz-Jeghers syndrome]]
| [[Peutz-Jeghers syndrome]]
| breast cancer, GI cancer, [[Sertoli cell tumour]], [[Granulosa cell tumour]], [[SCTAT]]
| breast cancer, GI cancer, [[Sertoli cell tumour]], [[Granulosa cell tumour]], [[SCTAT]]
| characteristic GI hamartomas, mucocutaneous pigmentation
| characteristic GI [[hamartoma]]s, mucocutaneous pigmentation
|-
|-
| PTEN
| PTEN
48,830

edits

Navigation menu